The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Challenges of drug resistance in the developing world
Abstract
Ramanan Laxminarayan and David Heymann examine the factors that make drug resistance a more difficult problem in poorer countries
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial resistance in developing countries. Part I: recent trends and current status
Okeke, I. N., Laxminarayan, R., Bhutta, Z. A., Duse, A. G., Jenkins, P., O'Brien, T. F., Pablos-Mendez, A., & Klugman, K. P. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70189-4 · Cited by 851
Self-citationMadhi, S. A., Petersen, K., Madhi, A., Khoosal, M., & Klugman, K. P. (2000) · Clinical Infectious Diseases · doi:10.1086/313925 · Cited by 254
Cited by
Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439
Self-citationGlobal antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
Van Boeckel, T. P., Gandra, S., Ashok, A., Caudron, Q., Grenfell, B. T., Levin, S. A., & Laxminarayan, R. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70780-7 · Cited by 2,280
Self-citationAccess to effective antimicrobials: a worldwide challenge
Laxminarayan, R., Matsoso, P., Pant, S., Brower, C., Røttingen, J.-A., Klugman, K., & Davies, S. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00474-2 · Cited by 1,465
Self-citationThe global threat of antimicrobial resistance: science for intervention.
Roca, I., Akova, M., Baquero, F., Carlet, J., Cavaleri, M., Coenen, S., Cohen, J., Findlay, D., Gyssens, I., Heure, O. E., et al. (2015) · New Microbes and New Infections · doi:10.1016/j.nmni.2015.02.007 · Cited by 1,106
“Of particular note is the use of antibiotics in low-income countries, where there are additional factors contributing to the emergence of resistance, including (a) less potent activity of some antibacterial agents (including counterfeit drugs), (b) over-the-counter availability, with insufficient dosages, (c) lack of…”
BackgroundSelf-citationAntibiotic Resistance in India: Drivers and Opportunities for Action
Laxminarayan, R., & Chaudhury, R. R. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1001974 · Cited by 545
Self-citationAuta, A., Hadi, M. A., Oga, E., Adewuyi, E. O., Abdu-Aguye, S. N., Adeloye, D., Strickland-Hodge, B., & Morgan, D. J. (2019) · Journal of Infection · doi:10.1016/j.jinf.2018.07.001 · Cited by 435
Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells
Garg, P., Malhotra, J., Kulkarni, P., Horne, D., Salgia, R., & Singhal, S. S. (2024) · Cancers · doi:10.3390/cancers16132478 · Cited by 339
Versporten, A., Bolokhovets, G., Ghazaryan, L., Abilova, V., Pyshnik, G., Spasojevic, T., Korinteli, I., Raka, L., Kambaralieva, B., Cizmovic, L., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70071-4 · Cited by 290
Belachew, S. A., Hall, L., Erku, D. A., & Selvey, L. A. (2021) · BMC Public Health · doi:10.1186/s12889-021-11163-3 · Cited by 73
“The consumption rate of antibiotics reported to continuously increase in LMICs [1, 4], partly driven by economic growth and prosperity [5].”
BackgroundKotwani, A., Joshi, J., Lamkang, A. S., Sharma, A., & Kaloni, D. (2021) · Pharmacy Practice · doi:10.18549/pharmpract.2021.1.2206 · Cited by 36
Cortez, J., Rosário, E., Pires, J. E., Taborda Lopes, J., Francisco, M., Vlieghe, E., & Brito, M. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.05.011 · Cited by 26
“Angola does not have national antibiotic treatment guidelines and has a lax regulatory system, similar to other developing countries (Laxminarayan and Heymann, 2012; Morgan et al., 2011; Holloway et al., 2016).”
Background
Metadata
- Authors
- Laxminarayan, R., & Heymann, D. L.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2012-04-03
- Volume
- 344
- Issue
- apr03 2
- Pages
- e1567-e1567
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W2030300388
- Cited by
- 191
- References
- 2
- FWCI
- 11.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.